|
|
Article: Accumetrics Announces $16.5M in New Capital Financing.
- Article from:
- Heart Disease Weekly
- Article date:
- October 25, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Accumetrics, Inc., developer and marketer of the VerifyNow=AE System, the first rapid and easy-to-use diagnostic system for measuring an individual's response to multiple antiplatelet agents, announced that it has completed a round of financing that will raise $16.5 million in new capital. The capital infusion, which will fully finance the company into 2011, came from the company's existing investors, including Arnerich Massena, BBT Fund/Apothecary Capital, Essex Woodlands Health Ventures, Kaiser Permanente Ventures and RiverVest Venture Partners (see also Accumetrics, Inc.).
Accumetrics' VerifyNow System helps physicians assess their patients' response to ...
Related newspaper, magazine, and journal articles:
|
|
Article: New life sciences study findings have been reported from ...
Heart Disease Weekly;
August 2, 2009 ;
700+ words
... ... Swaim and colleagues, Accumetrics (see also Life Sciences ... contact R.S. Hillman, Accumetrics Inc., 3985 Sorrento ... Hematology, Thrombolysis, Accumetrics. This article was prepared by Heart Disease Weekly editors from staff ...
|
|